CN103215388B - RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof - Google Patents
RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof Download PDFInfo
- Publication number
- CN103215388B CN103215388B CN201310172449.1A CN201310172449A CN103215388B CN 103215388 B CN103215388 B CN 103215388B CN 201310172449 A CN201310172449 A CN 201310172449A CN 103215388 B CN103215388 B CN 103215388B
- Authority
- CN
- China
- Prior art keywords
- vhsv
- pcr
- rna
- preparation
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000711825 Viral hemorrhagic septicemia virus Species 0.000 title claims abstract description 60
- 238000001514 detection method Methods 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000003757 reverse transcription PCR Methods 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000013518 transcription Methods 0.000 claims abstract description 35
- 230000035897 transcription Effects 0.000 claims abstract description 35
- 239000013641 positive control Substances 0.000 claims abstract description 30
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 22
- 239000013642 negative control Substances 0.000 claims abstract description 14
- 238000001179 sorption measurement Methods 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 45
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 38
- 239000012634 fragment Substances 0.000 claims description 28
- 238000012360 testing method Methods 0.000 claims description 20
- 238000000338 in vitro Methods 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 17
- 239000013612 plasmid Substances 0.000 claims description 16
- 239000012295 chemical reaction liquid Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 108010061100 Nucleoproteins Proteins 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 239000006166 lysate Substances 0.000 claims description 11
- 238000010839 reverse transcription Methods 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000013461 design Methods 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 108020000999 Viral RNA Proteins 0.000 claims description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 5
- 229910017604 nitric acid Inorganic materials 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 108091032955 Bacterial small RNA Proteins 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 239000013614 RNA sample Substances 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000007900 aqueous suspension Substances 0.000 claims description 3
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 238000011895 specific detection Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 238000012795 verification Methods 0.000 claims description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 2
- 230000009089 cytolysis Effects 0.000 abstract 2
- 241000700605 Viruses Species 0.000 description 14
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000711804 Infectious hematopoietic necrosis virus Species 0.000 description 3
- 241000710921 Infectious pancreatic necrosis virus Species 0.000 description 3
- 241000277331 Salmonidae Species 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 241000702652 Aquareovirus Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000277275 Oncorhynchus mykiss Species 0.000 description 2
- 208000001449 Viral Hemorrhagic Septicemia Diseases 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000036569 Carp sprivivirus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000160777 Hipparchia semele Species 0.000 description 1
- 241000546112 Infectious salmon anemia virus Species 0.000 description 1
- 241000701372 Iridovirus Species 0.000 description 1
- 241001112535 Novirhabdovirus Species 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 241001250103 Paralichthys lethostigma Species 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 241000277288 Salmo trutta Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241001312488 Sleeping disease virus Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000010460 detection of virus Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and a preparation method thereof, and relates to an RT-PCR detection kit. The RT-PCR detection kit for viral haemorrhagic septicaemia virus is provided with a kit body, an operation instruction and a detection reagent, wherein the operation instruction and the detection reagent are arranged in the kit body; and the detection reagent comprises a lysis solution, an adsorption solution, a washing solution, DEPC treatment water, an inverse transcription reaction solution, a VHSV-PCR reaction solution, a positive control and a negative control. The preparation method comprises the following steps of: preparing the detection reagent; and putting the operation instruction, the lysis solution, the adsorption solution, the washing solution, the DEPC treatment water, the inverse transcription reaction solution, the VHSV-PCR reaction solution, the positive control and the negative control into the kit body to obtain the RT-PCR detection kit for viral haemorrhagic septicaemia virus. The reagent is complete, and the operation is simple.
Description
Technical field
The present invention relates to a kind of RT-PCR detection kit, especially relate to RT-PCR detection kit of viral haemorrhagic septicaemia virus (Viral hemorrhagic septicemia virus, VHSV) and preparation method thereof.
Technical background
Viral hemorrhagic septicemia (Viral hemorrhagic septicemia, VHS) is a kind of lethality communicable disease that infects the multiple fish such as salmonid, trout, turbot, perch, Paralichthys lethostigma, brown trout, grayling.This disease causes fish-skin skin, kidney and liver hemorrhage, and mortality ratio is about 90%.The cause of disease of VHS is viral haemorrhagic septicaemia virus (VHSV), belongs to Rhabdoviridae Novirhabdovirus and belongs to.VHSV genome is one section of minus-strand RNA, the about 12kp of its length, 5 albumen of glm gene group coding, comprise: nucleocapsid protein (N albumen), two structural protein (P and M albumen), glycoprotein (G albumen), RNA polymerase (L albumen) and a Nonstructural Protein (NV albumen), order is 3 '-Leader-N-P-M-G-NV-L-Trailer-5 '.VHSV virus particle is about 180nm, wide about 70nm.In inward animal one, the two class transmissible disease registers of International Animal Health tissue and China, be all listed in and must report epidemic disease.International organization adopts some restrictions conventionally, thereby the fish that avoid catching an illness flow to other areas and national, and past VHS Major Epidemic is in North America and some countries of Europe.In recent years, along with the sharply increase of hydrocoles and products thereof foreign trade, VHSV has imported China into, and Bing China partial area are popular.
Reverse transcription chain polymerization enzyme reaction (RT-PCR) is a kind of for detection of virus and the most frequently used method of viroid, be applied in the detection of a series of fish disease virus, comprised: nona irido virus (Sleeping disease virus), Oncorhynchi infectious anemia syndrome virus (Infectious salmon anaemia virus), Aquareovirus (Fish aquareovirus), septicemia virus (Hemopoietic necrosis virus).
Viral haemorrhagic septicaemia virus lethality rate is very high, to cage culture, causes huge financial loss.The efficient manner of control virus infection is to prevent contact virus, carries out routine examination regularly, before and after fish transportation, carries out stricter detection.Avoid in principle the plant of contact infection, use the bait feeding of virus-free infection, use virus-free aquaculture water, using fish-egg is after testing the effective measure of controlling VHSV.Also there is no at present a kind of effective methods for the treatment of, therefore in initial infection, detect virus and just seem extremely important.This just needs that a kind of cost is low, quick, specificity and highly sensitive detection method.In the past few decades, set up the method for several detection viral haemorrhagic septicaemia virus.The detection method of traditional standard is first by cell cultures, to isolate virus, re-use special method as immunofluorescence monoclonal antibody (IFAT) or antibody neutralization test detection ([11] Fregeneda-GrandesJM, Olesen NJ.Detection of rainbow trout antibodies against viral haemorrhagicsepticaemia virus (VHSV) by neutralisation test is highly dependent on the virus isolate used.Dis Aquat Organ, 2007,74 (2): 151-158).In the GB GB/T15805.3-2008 of China 2008 Nian You State Administration for Quality Supervision and Inspection and Quarantine issue, also adopted the method.Enzyme-linked immunosorbent assay ([12] the Encinas P in addition commonly using at present, Gomez-Casado E, Estepa A, Coll JM.An ELISA for detection of trout antibodies to viral haemorrhagic septicemia virus using recombinant fragments of their viral G protein.J Virol Methods, 176 (1-2): 14-23) and real-time quantitative RT-PCR ([13] Chico V, Gomez N, Estepa A, Perez L.Rapid detection and quantitation of viral hemorrhagic septicemia virus in experimentally challenged rainbow trout by real-time RT-PCR.J Virol Methods, 2006, 132 (1-2): 154-159).But the length consuming time that these methods have, expensive equipment and reagent are used in some requirements.RT-PCR technology is a kind of quick, good and sensitive high method for detecting virus of specificity, is widely used in bait, aquaculture water and environmental monitoring.Also relevant for the report of VHSVRT-PCR detection method, still only reported and do not formed test kit by Auele Specific Primer in the past, during operation, need to buy a large amount of matched reagents, process is loaded down with trivial details.
Summary of the invention
The object of the present invention is to provide can specific detection viral haemorrhagic septicaemia virus primer.
RT-PCR detection kit providing a kind of viral haemorrhagic septicaemia virus and preparation method thereof is provided another object of the present invention.
According to published viral haemorrhagic septicaemia virus genome sequence, choose the nucleoprotein gene sequence of viral haemorrhagic septicaemia virus, analyze design, described primer that can specific detection viral haemorrhagic septicaemia virus is:
VHSN-F: its nucleotide sequence is as shown in SEQ ID NO.1;
VHSN-F: its nucleotide sequence is as shown in SEQ ID NO.2.
The RT-PCR detection kit of described viral haemorrhagic septicaemia virus is provided with box body, process specifications and detection reagent; Process specifications and detection reagent are located in box body, and described detection reagent comprises that lysate, adsorption liquid, washings, DEPC process water, inverse transcription reaction liquid, VHSV-PCR reaction solution, positive control and negative control.
The preparation method of the RT-PCR detection kit of described viral haemorrhagic septicaemia virus is as follows:
1) prepare box body;
2) preparation detection reagent:
Lysate is: 5mol/L Guanidinium hydrochloride, and 0.1mol/L EDTA, deionized water is settled to 1L, and pH is 8.0;
Adsorption liquid is: 5g glass powder is placed in 25～30mL water and is suspended, and then add isopyknic nitric acid reaction, finally again add aqueous suspension, the concentration of described nitric acid can be 68%;
Washings is: 0.1mol/L sodium-chlor, and 1mmol/L EDTA, 10mmol/L Tris-HCl, deionized water is settled to 1L, and pH is 7.5, then adds isopyknic dehydrated alcohol;
DEPC (diethylpyrocarbonate) processes water: toward adding DEPC in ultrapure water, to final concentration, be 0.1%, and after vibration 2h, autoclave sterilization 2 times;
Inverse transcription reaction liquid: every 6 μ L inverse transcription reaction liquids contain 1 μ L50mM VHSN-R primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 10mM; 2 μ L5 * Primescript damping fluids; 0.25 μ L RNase inhibitor; 0.25 μ L reversed transcriptive enzyme, purchased from the precious biotech firm of DaLian, China; 0.3 μ L glycerine; 1.2 μ L DEPC process water;
VHSV-PCR reaction solution: every 18 μ L VHSV-PCR reaction solutions contain 1 μ L10mM VHSN-F primer; 1 μ L10mM VHSN-F primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 2.5mM; 0.25 μ L Taq archaeal dna polymerase; 2 μ L10 * PCR damping fluids; 1.5 μ L glycerine; 11.25 μ L distilled water;
Negative control: DEPC processes water;
Positive control: the VHSV nucleoprotein gene RNA fragment that in-vitro transcription is obtained is diluted to 10
4copy/μ L gained solution;
3) process specifications, lysate, adsorption liquid, washings, DEPC are processed to water, inverse transcription reaction liquid, VHSV-PCR reaction solution, positive control and negative control and insert in box body, obtain the RT-PCR detection kit of viral haemorrhagic septicaemia virus.
In step 2) in, the preparation method of described positive control is as follows:
(1) design of primers, concrete grammar is:
According to acquired VHSV nucleoprotein gene sequence, design following two for building primer VHSV-long-F and the VHSV-long-R of in-vitro transcription VHSV nucleoprotein gene RNA fragment recombinant plasmid pSP-VHSV, carry respectively Hind III and BamH I restriction enzyme site:
VHSV-long-F: its nucleotide sequence is as shown in SEQ ID NO.3;
VHSV-long-R: its nucleotide sequence is as shown in SEQ ID NO.4;
(2) structure that contains testing goal fragment recombinant plasmid pSP-VHSV and as the preparation of the RNA fragment of positive control, concrete steps are:
A) structure of pSP-VHSV recombinant plasmid
Use VHSV-long-R as reverse transcription primer, using viral RNA sample as template, through reverse transcription PCR reaction, obtained object fragment, then the reverse transcription product of acquisition is carried out to pcr amplification as template, after PCR product is reclaimed, with Hind III and BamH I restriction endonuclease, do double digestion, re-use E.Z.N.A.
tMcycle Pure test kit (OMEGA, USA) reclaims enzyme and cuts product, then enzyme is cut to product and is connected on pSP64poly (A) (Promega, USA) carrier, is converted in competence E.coliDH5 α screening positive clone sequence verification;
B) in-vitro transcription obtains the RNA fragment as positive control
The pSP-VHSV plasmid that extraction builds, reclaims plasmid after EcoRI linearizing, then obtains small RNA fragments by Promega in-vitro transcription test kit in-vitro transcription, with 1.2% agarose gel electrophoresis and spectrophotometer, detects RNA quality and concentration; According to RNA molecular weight, determine unit volume RNA molecule number, by 10 times of gradient dilutions, dilution is 1 * 10 respectively
6to 1 * 10
1copy/μ L, the positive RNA fragment of acquisition concentration gradient.
The present invention has designed two pairs of new primers according to VHSV nucleoprotein (N) gene order and has detected for the RT-PCR of VHSV, and has detected specificity and the sensitivity of this primer; In-vitro transcription a bit of viral RNA as positive control, thereby set up the VHSV detection kit of rapid sensitive.
The invention provides a kind of special, easy and viral haemorrhagic septicaemia virus detection kit fast, reagent is complete, simple to operate, for providing testing tool to popular detection and the prevention and control of this disease later.
Accompanying drawing explanation
Fig. 1 is the RT-PCR detection kit cross section view (being composition and the position view arranging in box) of viral haemorrhagic septicaemia virus.In Fig. 1, be respectively labeled as: 1: lysate, 2: washings, 3: box body, 4: process specifications, 5: adsorption liquid, 6:DEPC process water, 7: inverse transcription reaction liquid, 8:VHSV-PCR reaction solution, 9: positive control:, 10: negative control.
Fig. 2 is embodiment 1 primer specificity experiment electrophorogram.In Fig. 2, M is DL Marker2000(Takara, China); 1 positive contrast (VHSV transcribes gained RNA fragment), 2 is VHSV, and 3 is IHNV, and 4 is IPNV, and 5 is SVCV, 6 negative contrasts.
Fig. 3 is embodiment 2 sensitivity test experience electrophorograms.In Fig. 3, M is DL Marker2000(Takara, China); 1～6 is 2 * 10
6, 2 * 10
5, 2 * 10
4, 2 * 10
3, 2 * 10
2, 2 * 10
1copy/μ L in-vitro transcription gained positive control RNA; 7 negative contrasts.
Fig. 4 is embodiment 3 rate of recovery experiment electrophorograms.In Fig. 4, M is DL Marker2000(Takara, China); 1～3 is 2 * 10
6, 2 * 10
5, 2 * 10
4copy/μ L in-vitro transcription gained positive control RNA; 4～6 is 2 * 10
6, 2 * 10
5, 2 * 10
4the RNA reclaiming after copy/μ L positive control RNA biased sample; 7 negative contrasts.
Embodiment
One, Auele Specific Primer of the present invention, according to published viral haemorrhagic septicaemia virus genome sequence, choose the nucleoprotein gene sequence of viral haemorrhagic septicaemia virus, analyze design, can specificity differentiate viral haemorrhagic septicaemia virus, this comprises two to primer:
VHSV-F: its nucleotide sequence is as shown in SEQ ID NO.1;
VHSV-R: its nucleotide sequence is as shown in SEQ ID NO.2.
Two, the RT-PCR detection kit of viral haemorrhagic septicaemia virus of the present invention is provided with box body 3, process specifications 4 and detection reagent; Process specifications 4 and detection reagent are located in box body 3, and described detection reagent comprises that lysate 1, adsorption liquid 5, washings 2, DEPC process water 6, inverse transcription reaction liquid 7, VHSV-PCR reaction solution 8, positive control 9, negative control 10(referring to Fig. 1);
The preparation method of the RT-PCR detection kit of described viral haemorrhagic septicaemia virus is as follows:
1. prepare box body;
2. prepare detection reagent:
Lysate is: 5mol/L Guanidinium hydrochloride, and 0.1mol/L EDTA, deionized water is settled to 1L, and pH is 8.0;
Adsorption liquid is: 5g glass powder is placed in 25-30mL water and is suspended, and then add the nitric acid reaction of equal-volume concentration 68%, finally again add aqueous suspension.
Washings is: 0.1mol/L sodium-chlor, and 1mmol/L EDTA, 10mmol/L Tris-HCl, deionized water is settled to 1L, and pH is 7.5, then adds isopyknic dehydrated alcohol;
DEPC (diethylpyrocarbonate) processes water: toward adding DEPC in ultrapure water, to final concentration, be 0.1%, and after vibration 2h, autoclave sterilization 2 times.
Inverse transcription reaction liquid: every 6 μ L inverse transcription reaction liquids contain 1 μ L50mM VHSV-R primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 10mM; 2 μ L5 * Primescript damping fluids; 0.25 μ LRNase inhibitor; 0.25 μ L reversed transcriptive enzyme, purchased from the precious biotech firm of DaLian, China; 0.3 μ L glycerine; 1.2 μ L DEPC process water.
VHSV-PCR reaction solution: every 18 μ L VHSV-PCR reaction solutions contain 1 μ L10mMVHSV-F primer; 1 μ L10mM VHSV-R primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 2.5mM; 0.25 μ L Taq archaeal dna polymerase; 2 μ L10 * PCR damping fluids; 1.5 μ L glycerine; 11.25 μ L distilled water.
Negative control: DEPC processes water.
Positive control: the VHSV nucleoprotein gene RNA fragment that in-vitro transcription is obtained is diluted to 10
4copy/μ L gained solution.
In step 2, the preparation method of described positive control is as follows:
Step 1, design of primers, concrete grammar is:
According to acquired VHSV nucleoprotein gene sequence, design following two for building primer VHSV-long-F and the VHSV-long-R of in-vitro transcription VHSV nucleoprotein gene RNA fragment recombinant plasmid pSP-VHSV, carry respectively Hind III and BamH I restriction enzyme site:
VHSV-long-F: its nucleotide sequence is as shown in SEQ ID NO.3;
VHSV-long-R: its nucleotide sequence is as shown in SEQ ID NO.4.
Step 2, the structure that contains testing goal fragment recombinant plasmid pSP-VHSV and as the preparation of the RNA fragment of positive control, concrete steps are:
1) structure of pSP-VHSV recombinant plasmid
Use VHSV-long-R as reverse transcription primer, using viral RNA sample as template, through reverse transcription PCR reaction, obtained object fragment.Its reverse transcription reaction system and response procedures are as follows:
Mix rear 42 ℃ of reaction 1h, after 70 ℃ of reaction 15min termination reactions, be placed in rapidly on ice, then the reverse transcription product of acquisition is carried out to pcr amplification as template, reaction system and response procedures are as follows:
PCR program is: 95 ℃ of 3min; 94 ℃ of 30s, 58 ℃ of 30s, 72 ℃ of 30s, 35 circulations; 72 ℃ of 5min;
After PCR product is reclaimed, with Hind III and BamH I restriction endonuclease, do double digestion, re-use E.Z.N.A.
tMcycle Pure test kit (OMEGA, USA) reclaims enzyme and cuts product, then enzyme is cut to product and is connected on pSP64poly (A) (Promega, USA) carrier, is converted in competence E.coliDH5 α screening positive clone sequence verification;
2) in-vitro transcription obtains the RNA fragment as positive control
The pSP-VHSV plasmid that extraction builds, reclaims plasmid after EcoRI linearizing, then obtains small RNA fragments by Promega in-vitro transcription test kit in-vitro transcription.In-vitro transcription system and condition are as follows:
Adding DEPC processing water to final volume is 20 μ L.
Centrifugal be placed on 37 ℃ reaction 1h, after having reacted, add RQ1RNase-Free DNase2u, hatch 30min digestion for 37 ℃ and remove pSP-VHSV plasmid, phenol/chloroform/primary isoamyl alcohol (25: 24: 1) and chloroform/primary isoamyl alcohol (24: 1) extracting RNA, then detect RNA quality and concentration with 1.2% agarose gel electrophoresis and spectrophotometer; According to RNA molecular weight, determine unit volume RNA molecule number, by 10 times of gradient dilutions, dilution is 1 * 10 respectively
6to 1 * 10
1copy/μ L, the positive RNA fragment of acquisition concentration gradient.
3. by detection reagent: process specifications, lysate, adsorption liquid, washings, DEPC process water, inverse transcription reaction liquid, VHSV-PCR reaction solution, positive control and negative control and insert in box body, obtain the RT-PCR detection kit of viral haemorrhagic septicaemia virus.The quality of stochastic sampling detection kit again.
Three, the application of the RT-PCR detection kit of viral haemorrhagic septicaemia virus is as follows:
1. the sample of obtaining is added in 0.5mL centrifuge tube, then adds and manage 8 of interior lysates for No. 1, with toothpick, fully smash (approximately 1～2min) to pieces.
The centrifugal 3min of 2.12000r/min, is transferred to supernatant in new 0.5mL centrifuge tube, adds the adsorption liquid (include white mass, fully shake up with front) in 30 μ L5 pipes, mixes.Room temperature is placed 5min, during vibrate 3 times.
The centrifugal 30s of 3.12000r/min, abandons supernatant, more centrifugal 3s, with pipettor, blots residual liquid, adds 10 of No. 2 washingss in pipe, stirs and makes to precipitate abundant suspension gently.
The centrifugal 30s of 4.12000r/min, abandons supernatant, more centrifugal 3s, with pipettor, blots residual liquid, and room temperature is placed 3min.
5. add 20 μ LDEPC to process water, abundant dissolution precipitation, the centrifugal 30s of 12000r/min, the inverse transcription reaction liquid 6 μ L that draw in supernatant 4 μ L and No. 7 pipes are added in 0.5mL centrifuge tube, hatch 0.5h for 42 ℃, again the VHSV-PCR reaction solution of reverse transcription product 2 μ L and 18 μ L8 pipes is mixed, carry out PCR reaction.PCR reaction parameter is set to: first 95 ℃ of pre-treatment 1min, carry out 35 circulating reactions, and each circulation comprises 94 ℃ of 30s, 58 ℃ of 30s, 72 ℃ of 30s, after having circulated, 72 ℃ are extended 10min.The negative control of the positive control of No. 9 pipes and No. 10 pipes does not need to process, and directly gets 4 μ L and carries out reverse transcription and follow-up PCR reaction, and reaction conditions detects identical with previous sample.
6. result is judged: PCR reaction is complete, gets 10 μ L reaction product electrophoresis detection on 1.5% sepharose, time 15～25min.Under ultraviolet lamp, observe, positive control should have the clear band of a 471bp; Negative control at this parallel position without band; If sample has band at this parallel position, show that this sample may contain viral haemorrhagic septicaemia virus, if do not contain viral haemorrhagic septicaemia virus in sample without band.
Remarks: when test kit is not used, 7,8,9 and No. 10 reagent-20 ℃ preservations, 4 ℃ of preservations of all the other reagent behind Kaifeng, should be finished in 6 months.
Below in conjunction with specific embodiment, the present invention is further elaborated, but specific embodiment is not done any restriction to the present invention.
The specificity experiment of embodiment 1 primer
In order to determine the specificity of this RT-PCR detection kit, use respectively other viral RNAs or DNA as template, using method according to test kit detects, described other viruses comprise infectious hematopoietic necrosis's virus (Infectious hematopoietic necrosis virus, IHNV), pancreas necrosis virus (Infectious pancreatic necrosis virus, IPNV) and carp pure blood disease necrosis virus (Spring viremia of carp virus, SVCV).Experimental result shows: except viral haemorrhagic septicaemia virus, all can't detect the object fragment (see figure 2) of 471bp after other viral agarose gel electrophoresis.Illustrate that this detection kit primer specificity used is good.
Embodiment 2 sensitivity test experience
Get 2 μ L different concns gradients (1 * 10
6-1 * 10
1copy/μ L) positive control RNA fragment detects according to the using method of test kit as template, then uses 1.5% agarose gel electrophoresis detected result, and result shows (see figure 3), and the method can detect and be approximately 10
2individual positive RNA, had both been equivalent to 10
2individual virus particle.
Embodiment 3 rate of recovery experiments
In order to analyze the efficiency of extracting viral RNA from sample, carried out rate of recovery experiment.By 20 μ L1 * 10
6, 1 * 10
5, 1 * 10
4the positive control RNA of copy/μ L and negative sample mix, and according to the using method of test kit, extract RNA, RNA is dissolved in to 20 μ LDEPC and processes in water.Then with each concentration gradient positive control RNA of 2 μ L and the new RNA extracting, as template, detect respectively.The demonstration of agarose gel electrophoresis detected result, the rate of recovery of this extracting method is greater than 50%(and sees Fig. 4).
Claims (5)
1. primer that can specific detection viral haemorrhagic septicaemia virus, is characterized in that described primer is:
VHSN-F: its nucleotide sequence is as shown in SEQ ID NO.1;
VHSN-F: its nucleotide sequence is as shown in SEQ ID NO.2.
2. the RT-PCR detection kit of viral haemorrhagic septicaemia virus, is characterized in that being provided with box body, process specifications and detection reagent; Process specifications and detection reagent are located in box body, and described detection reagent comprises that lysate, adsorption liquid, washings, DEPC process water, inverse transcription reaction liquid, VHSV-PCR reaction solution, positive control and negative control.
3. the preparation method of the RT-PCR detection kit of viral haemorrhagic septicaemia virus as claimed in claim 2, is characterized in that comprising the following steps:
1) prepare box body;
2) preparation detection reagent:
Lysate is: 5mol/L Guanidinium hydrochloride, and 0.1mol/L EDTA, deionized water is settled to 1L, and pH is 8.0;
Adsorption liquid is: 5g glass powder is placed in 25～30mL water and is suspended, and then add isopyknic nitric acid reaction, finally again add aqueous suspension;
Washings is: 0.1mol/L sodium-chlor, and 1mmol/L EDTA, 10mmol/L Tris-HCl, deionized water is settled to 1L, and pH is 7.5, then adds isopyknic dehydrated alcohol;
DEPC processes water: toward adding DEPC in ultrapure water, to final concentration, be 0.1%, and after vibration 2h, autoclave sterilization 2 times;
Inverse transcription reaction liquid: every 6 μ L inverse transcription reaction liquids contain 1 μ L50mM VHSN-R primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 10mM; 2 μ L5 * Primescript damping fluids; 0.25 μ L RNase inhibitor; 0.25 μ L reversed transcriptive enzyme, purchased from the precious biotech firm of DaLian, China; 0.3 μ L glycerine; 1.2 μ L DEPC process water;
VHSV-PCR reaction solution: every 18 μ L VHSV-PCR reaction solutions contain 1 μ L10mM VHSN-F primer; 1 μ L10mMVHSN-F primer; 1 μ L dNTP mixture, every kind of dNTP concentration is 2.5mM; 0.25 μ L Taq archaeal dna polymerase; 2 μ L10 * PCR damping fluids; 1.5 μ L glycerine; 11.25 μ L distilled water;
Negative control: DEPC processes water;
Positive control: the VHSV nucleoprotein gene RNA fragment that in-vitro transcription is obtained is diluted to 10
4copy/μ L gained solution;
3) process specifications, lysate, adsorption liquid, washings, DEPC are processed to water, inverse transcription reaction liquid, VHSV-PCR reaction solution, positive control and negative control and insert in box body, obtain the RT-PCR detection kit of viral haemorrhagic septicaemia virus.
4. the preparation method of the RT-PCR detection kit of viral haemorrhagic septicaemia virus as claimed in claim 3, is characterized in that in step 2) in, the preparation method of described positive control is as follows:
(1) design of primers, concrete grammar is:
According to acquired VHSV nucleoprotein gene sequence, design following two for building primer VHSV-long-F and the VHSV-long-R of in-vitro transcription VHSV nucleoprotein gene RNA fragment recombinant plasmid pSP-VHSV, carry respectively Hind III and BamH I restriction enzyme site:
VHSV-long-F: its nucleotide sequence is as shown in SEQ ID NO.3;
VHSV-long-R: its nucleotide sequence is as shown in SEQ ID NO.4;
(2) structure that contains testing goal fragment recombinant plasmid pSP-VHSV and as the preparation of the RNA fragment of positive control, concrete steps are:
A) structure of pSP-VHSV recombinant plasmid
Use VHSV-long-R as reverse transcription primer, using viral RNA sample as template, through reverse transcription PCR reaction, obtained object fragment, then the reverse transcription product of acquisition is carried out to pcr amplification as template, after PCR product is reclaimed, with Hind III and BamH I restriction endonuclease, do double digestion, re-use E.Z.N.A.
tMcycle Pure test kit (OMEGA, USA) reclaims enzyme and cuts product, then enzyme is cut to product and is connected on pSP64poly (A) (Promega, USA) carrier, is converted in competence E.coliDH5 α screening positive clone sequence verification;
B) in-vitro transcription obtains the RNA fragment as positive control
The pSP-VHSV plasmid that extraction builds, reclaims plasmid after EcoRI linearizing, then obtains small RNA fragments by Promega in-vitro transcription test kit in-vitro transcription, with 1.2% agarose gel electrophoresis and spectrophotometer, detects RNA quality and concentration; According to RNA molecular weight, determine unit volume RNA molecule number, by 10 times of gradient dilutions, dilution is 1 * 10 respectively
6to 1 * 10
1copy/μ L, the positive RNA fragment of acquisition concentration gradient.
5. the preparation method of the RT-PCR detection kit of viral haemorrhagic septicaemia virus as claimed in claim 3, is characterized in that in step 2) in, the concentration of described nitric acid is 68%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310172449.1A CN103215388B (en) | 2013-05-10 | 2013-05-10 | RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310172449.1A CN103215388B (en) | 2013-05-10 | 2013-05-10 | RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103215388A CN103215388A (en) | 2013-07-24 |
| CN103215388B true CN103215388B (en) | 2014-11-26 |
Family
ID=48813536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310172449.1A Expired - Fee Related CN103215388B (en) | 2013-05-10 | 2013-05-10 | RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103215388B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105112567A (en) * | 2015-09-14 | 2015-12-02 | 山东出入境检验检疫局检验检疫技术中心 | Viral hemorrhagic septicemia virus detection kit based on pyrosequencing |
| CN105543413B (en) * | 2016-01-25 | 2019-01-22 | 山东出入境检验检疫局检验检疫技术中心 | Viral haemorrhagic septicaemia virus visualizes nucleic acid test strip detection primer group and detection method |
| CN110592272A (en) * | 2018-06-13 | 2019-12-20 | 杭州众测生物科技有限公司 | RAA constant temperature fluorescence detection method and reagent for Viral Hemorrhagic Septicemia (VHSV) |
| CN110387440B (en) * | 2019-09-06 | 2020-08-11 | 深圳海关动植物检验检疫技术中心 | Reagent for multiple detection of salmon and trout viruses and application thereof |
| KR20240038884A (en) * | 2022-09-16 | 2024-03-26 | 재단법인 대구경북첨단의료산업진흥재단 | Composition For Detecting Viral Hemorrhagic Septicemia Virus, Kit For Detecting the Same and Method of Detecting VHSV Using the Same based on loop mediated isothermal amplification combined with CRISPR/Cas diagnosis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1687447A (en) * | 2005-04-12 | 2005-10-26 | 中华人民共和国连云港出入境检验检疫局 | Kit for testing three kinds of viruses of fish diseases synchronistically and test method thereof |
| CN1775954A (en) * | 2005-04-12 | 2006-05-24 | 中华人民共和国连云港出入境检验检疫局 | Method for preparing positive control for single-tube RT-PCR detection of three fish disease virus |
| CN101948937A (en) * | 2010-10-15 | 2011-01-19 | 国家海洋局第三海洋研究所 | PCR detection kit and detection method of epizootic haematopoietic necrosis virus (EHNV) |
-
2013
- 2013-05-10 CN CN201310172449.1A patent/CN103215388B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1687447A (en) * | 2005-04-12 | 2005-10-26 | 中华人民共和国连云港出入境检验检疫局 | Kit for testing three kinds of viruses of fish diseases synchronistically and test method thereof |
| CN1775954A (en) * | 2005-04-12 | 2006-05-24 | 中华人民共和国连云港出入境检验检疫局 | Method for preparing positive control for single-tube RT-PCR detection of three fish disease virus |
| CN101948937A (en) * | 2010-10-15 | 2011-01-19 | 国家海洋局第三海洋研究所 | PCR detection kit and detection method of epizootic haematopoietic necrosis virus (EHNV) |
Non-Patent Citations (5)
| Title |
|---|
| Miller TA et al..Rapid and sensitive reverse transcriptase-polymerase chain reaction based detection and differential diagnosis of fish pathogenic rhabdoviruses in organ samples and cultured cells..《Diseases of Aquatic Organisms》.1998,第34卷13-20. * |
| Rapid and sensitive reverse transcriptase-polymerase chain reaction based detection and differential diagnosis of fish pathogenic rhabdoviruses in organ samples and cultured cells.;Miller TA et al.;《Diseases of Aquatic Organisms》;19980911;第34卷;13-20 * |
| 倪穗 等.应用巢式逆转录聚合酶链式反应检测鱼类病毒性出血性败血症病毒(vhsv).《海洋与湖沼》.2009,第40卷(第4期),489-493. * |
| 应用巢式逆转录聚合酶链式反应检测鱼类病毒性出血性败血症病毒(vhsv);倪穗 等;《海洋与湖沼》;20090731;第40卷(第4期);489-493 * |
| 黄辉三 等.流行性造血器官坏死病毒（EHNV）PCR快速检测试剂盒的研制.《台湾海峡》.2011,第30卷(第1期),128-131. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103215388A (en) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103215388B (en) | RT-PCR (reverse transcription-polymerase chain reaction) detection kit for viral haemorrhagic septicaemia virus and preparation method thereof | |
| CN106636471B (en) | Multiplex PCR detection kit for simultaneously detecting WSSV, AHPND, EHP and IHHNV of prawns | |
| Provost et al. | Hemocytes are sites of enteric virus persistence within oysters | |
| Williams et al. | Multiplex reverse transcriptase PCR assay for simultaneous detection of three fish viruses | |
| Borzym et al. | First isolation of hirame rhabdovirus from freshwater fish in E urope | |
| CN108950068B (en) | Kit for identifying and detecting QX-type strains of chicken infectious bronchitis viruses | |
| Zhang et al. | Isolation and identification of a viral haemorrhagic septicaemia virus (VHSV) isolate from wild largemouth bass Micropterus salmoides in China | |
| CN105463136B (en) | Kit for the detection of avian infectious bronchitis virus RT-PCR partings | |
| CN103233005B (en) | Reverse transcription-polymerase chain reaction (RT-PCR) detection kit for infectious haematopoietic necrosis viruses (IHNV) and preparation method of kit | |
| CN102876810A (en) | RT-PCR (reverse transcription-polymerase chain reaction) detection kit and detection method for spring viraemia of carp virus | |
| Işıdan et al. | A survey of viral hemorrhagic septicemia (VHS) in Turkey | |
| Zeng et al. | A one‐step molecular biology method for simple and rapid detection of grass carp Ctenopharyngodon idella reovirus (GCRV) HZ08 strain | |
| CN104862421B (en) | The complete sets of products of identification rabies, canine distemper, catarrhal jaundice, parvovirus, leptospirosis and toxoplasmosis cause of disease | |
| Ito et al. | Vaccination against cyprinid herpesvirus 2 (CyHV-2) infection in goldfish Carassius auratus | |
| El-Matbouli et al. | Detection of Cyprinid herpesvirus-3 (CyHV-3) DNA in infected fish tissues by nested polymerase chain reaction | |
| CN102321769B (en) | Primer pair for identifying newcastle disease virus and multi-subtype avian influenza virus and application thereof | |
| CN104946798A (en) | Primer and method for detecting tobacco mosaic virus LAMP | |
| CN103451315A (en) | Loop-mediated isothermal amplification detection primer set and kit for rotaviruses as well as detection method | |
| CN106480173B (en) | The poultry immunities such as bird flu inhibit pathogen Multiple detection reagent and its application | |
| CN105296669A (en) | RT-LAMP detection primer pairs, kit and detection method for infectious haematopoietic necrosis virus (IHNV) | |
| CN102304591B (en) | PCR (polymerase chain reaction) primer pair for identifying H3 subtype avian influenza virus and application thereof | |
| CN105695629A (en) | Primers and method for identifying genotype I and genotype II DRVs (duck reoviruses) | |
| Barlič‐Maganja et al. | Comparison of the efficiency and sensitivity of virus isolation and molecular methods for routine diagnosis of infectious haematopoietic necrosis virus and infectious pancreatic necrosis virus | |
| CN110628951A (en) | Fluorescence quantitative PCR (polymerase chain reaction) on-site rapid detection kit for African swine fever virus | |
| CN105177178A (en) | Tobacco mosaic virus LAMP detection kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 |